All Stories

  1. Minimal clinically-important differences for the ‘Liverpool Osteoarthritis in Dogs’ (LOAD) and the ‘Canine Orthopedic Index’ (COI) client-reported outcomes measures
  2. Understanding the mechanisms that drive pain sensation in arthritic joints
  3. A humeral intracondylar repair system for the management of humeral intracondylar fissure and humeral condylar fracture
  4. In response to: “Same‐day surgery may reduce the risk of losing pain perception in dogs with thoracolumbar disc extrusion”
  5. Investigation of Variables Associated with Surgical Site Infection following the Management of Canine Cranial Cruciate Ligament Rupture with a Lateral Fabellotibial Suture
  6. An In Vitro Comparison of the Neurotrophic and Angiogenic Activity of Human and Canine Adipose-Derived Mesenchymal Stem Cells (MSCs): Translating MSC-Based Therapies for Spinal Cord Injury
  7. Elbow Arthrodesis Using a Medially Positioned Plate in 6 Dogs
  8. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
  9. Exposing mesenchymal stem cells to chondroitin sulphated proteoglycans reduces their angiogenic and neuro-adhesive paracrine activity
  10. Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST)
  11. Interaction with macrophages attenuates equine fibroblast-like synoviocyte ADAMTS5 (aggrecanase-2) gene expression following inflammatory stimulation
  12. Evaluation of variables influencing success and complication rates in canine total hip replacement: results from the British Veterinary Orthopaedic Association Canine Hip Registry (collation of data: 2010–2012)
  13. The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint
  14. Variation in the Quantity of Elastic Fibres with Degeneration in Canine Cranial Cruciate Ligaments from Labrador Retrievers
  15. Canine mesenchymal stem cells are neurotrophic and angiogenic: An in vitro assessment of their paracrine activity
  16. Peak Vertical Force and Vertical Impulse in Dogs With Cranial Cruciate Ligament Rupture and Meniscal Injury
  17. Mechanical Testing of a Synthetic Canine Gastrocnemius Tendon Implant
  18. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain
  19. Mechanical performance in axial compression of a titanium polyaxial locking plate system in a fracture gap model
  20. Ex vivo kinematic studies of a canine unlinked semi-constrained hybrid total elbow arthroplasty system
  21. Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial
  22. Genome-wide association study identifies genomic regions of association for cruciate ligament rupture in Newfoundland dogs
  23. Genetic basis of cranial cruciate ligament rupture (CCLR) in dogs
  24. Intra-articular botulinum toxin A for the treatment of osteoarthritic joint pain in dogs: A randomized, double-blinded, placebo-controlled clinical trial
  25. Elastin content is high in the canine cruciate ligament and is associated with degeneration
  26. Evaluation of cartilage, synovium and adipose tissue as cellular sources for osteochondral repair
  27. Evaluation of Construct and Criterion Validity for the ‘Liverpool Osteoarthritis in Dogs’ (LOAD) Clinical Metrology Instrument and Comparison to Two Other Instruments
  28. Ethical and evidential considerations on the use of novel therapies in veterinary practice
  29. Variations in cell morphology in the canine cruciate ligament complex
  30. Complications and Owner Assessment of Canine Total Hip Replacement: A Multicenter Internet Based Survey
  31. The organisation of elastin and fibrillins 1 and 2 in the cruciate ligament complex
  32. Veterinary tissue banking and bone transplantation
  33. Observer variation in the evaluation and classification of severe central tarsal bone fractures in racing Greyhounds
  34. Development of an in vitro model of feline cartilage degradation
  35. Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis
  36. Biomarkers of cartilage turnover. Part 2: Non-collagenous markers
  37. Comparative rheumatology: what can be learnt from naturally occurring musculoskeletal disorders in domestic animals?
  38. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis
  39. Demineralised bone matrix in veterinary orthopaedics: A review
  40. A Candidate Gene Study of Canine Joint Diseases
  41. Effect of surgical technique on radiographic fusion of the anconeus in the treatment of ununited anconeal process
  42. An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitromodel
  43. Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis
  44. Systematic review of the management of canine osteoarthritis
  45. High-intensity exercise induces structural, compositional and metabolic changes in cuboidal bones — findings from an equine athlete model
  46. Relationship Between Objective and Subjective Assessment of Limb Function in Normal Dogs with an Experimentally Induced Lameness
  47. Gene expression profiling of normal and ruptured canine anterior cruciate ligaments
  48. Arthroscopic management of a lateral glenohumeral ligament rupture in two dogs
  49. Outcomes-Based Medicine in Veterinary Surgery: Levels of Evidence
  50. DNA archive for companion animals
  51. Partial tarsal arthrodesis and botulinum toxin A injection for correction of tarsal arthrogryposis in a cat
  52. Infection of a total hip prosthesis in a dog caused by Achromobacter (Alcaligenes) xylosoxidans
  53. Use of biochemical markers of osteoarthritis to investigate the potential disease-modifying effect of tibial plateau levelling osteotomy
  54. Assessment of the use of RNA quality metrics for the screening of articular cartilage specimens from clinically normal dogs and dogs with osteoarthritis
  55. Genetic basis of secondary osteoarthritis in dogs with joint dysplasia
  56. Distal femoral intercondylar notch dimensions and their relationship to composition and metabolism of the canine anterior cruciate ligament
  57. Ultrastructural Differences in Cranial Cruciate Ligaments from Dogs of Two Breeds with a Differing Predisposition to Ligament Degeneration and Rupture
  58. Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis
  59. Distribution of power across the hind limb joints in Labrador Retrievers and Greyhounds
  60. Bilateral fixation of Y‐T humeral condyle fractures via medial and lateral approaches in 29 dogs
  61. Nutraceutical Therapies for Degenerative Joint Diseases: A Critical Review
  62. Metabolism and composition of the canine anterior cruciate ligament relate to differences in knee joint mechanics and predisposition to ligament rupture
  63. Treatment of shoulder instability caused by medial glenohumeral ligament rupture with thermal capsulorrhaphy
  64. Investigation of the composition, turnover, and thermal properties of ruptured cranial cruciate ligaments of dogs
  65. Radiographic Progression of Osteoarthritis of the Canine Stifle Joint: A Prospective Study
  66. Progression of osteoarthritis following TPLO surgery: a prospective radiographic study of 40 dogs
  67. Rupture of the biceps brachii tendon sheath in two dogs
  68. Randomised, double-blind, placebocontrolled parallel group study of P54FP for the treatment of dogs with osteoarthritis
  69. Ultrasound Imaging of the Intervertebral Disc
  70. Thoracolumbar disc disease in large dogs: a study of 99 cases
  71. CHANGES IN THE CANINE FEMOROPATELLAR JOINT SPACE IN THE POSTSURGICAL, CRUCIATE-DEFICIENT STIFLE JOINT
  72. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs
  73. Pressure profilometry of the lumbosacral disk in dogs
  74. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis
  75. Incomplete humeral condylar fractures in the dog
  76. Lateral glenohumeral ligament rupture in three dogs
  77. Long-term outcome of surgery for dogs with cranial cruciate ligament deficiency
  78. Efficacy of oral calcium pentosan polysulphate for the treatment of osteoarthritis of the canine stifle joint secondary to cranial cruciate ligament deficiency
  79. Can owners assess outcome following treatment of canine cruciate ligament deficiency?
  80. Clinical natural history of the postsurgical cruciate deficient canine stifle joint: year 1
  81. Discospondylitis in an adult horse